COVID-19

Amendment to ‘Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19’

BMJ Publishing Group Ltd

10.1136/jitc-2020-000878corr1Amendment

August 25, 2020

Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA

Pedro Barata, Neeraj Agarwal, Roberto Nussenzveig, Benjamin Gerendash, Ellen Jaeger, Whitley Hatton, Elisa Ledet, Brian Lewis, Jodi Layton, Hani Babiker, Alan Bryce, Rohan Garje, Cy Stein, Lesli Kiedrowski, Philip Saylor, Oliver Sartor

10.1136/jitc-2020-001065

August 11, 2020

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Marcello Curvietto, Domenico Mallardo, Egidio Celentano, Antonio Maria Grimaldi, Marco Palla, Claudia Trojaniello, Maria Grazia Vitale, Samuel Lewis Million-Weaver, Paolo Antonio Ascierto

10.1136/jitc-2020-001089

August 11, 2020

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity

Jia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou

10.1136/jitc-2020-000862

July 29, 2020

Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment

Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora

10.1136/jitc-2020-000952

July 21, 2020

ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19

Riyue Bao, Kyle Hernandez, Lei Huang, Jason John Luke

10.1136/jitc-2020-001020

July 15, 2020

BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy

Madhuri Koti, Alvaro Morales, Charles H Graham, David Robert Siemens

10.1136/jitc-2020-001119

July 6, 2020

Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

Brendan Curti, Marka Crittenden, Steven K Seung, Christopher B Fountain, Roxanne Payne, ShuChing Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick, Walter J Urba

10.1136/jitc-2020-000773

May 27, 2020

COVID-19 and lung cancer: risks, mechanisms and treatment interactions

Alfredo Addeo, Michel Obeid, Alex Friedlaender

10.1136/jitc-2020-000892

May 19, 2020

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy

Michael T Serzan, Princy N Kumar, Michael B Atkins

10.1136/jitc-2020-000898

May 19, 2020